// App-Quantinova.ai

BSH19‐OR‐033 : A novel shear flow‐based assay to assess treatment response in congenital thrombotic thrombocytopenic purpura

Researchers

Presenter

  • F. Alwan

Principal Investigators

  • C. Vendramin

  • M. Thomas

  • M. Scully

Medical Centers

  • Department of Hematology,

  • Haemostasis Research Unit, UCLH, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Thrombotic thrombocytopenic purpura

Biomarkers

  • von Willebrand factor

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • thrombospondin-1

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A